BARCLAY ALEC (See Remarks) sold 9.1% of their position (4.21K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $12.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/13/2019ACC: 0000899243-19-023537
Officer· See Remarks
Since Jul 2018
+205.79K
Net shares
Net buyer
$12.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
210K acquired · 4.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
27.5%
9/11/2019
36.31K→46.31K
Common Stock
Direct
Shares
−4.21K
Price / share
$2.92
Trade value
$12.29K
% of position
9.1%
9/11/2019
46.31K→42.10K
Total
Net shares
+5.79K
Net value
-$12.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2019 | M · Option Exercise | +10K | — | — | 27.5% | 36.31K | 46.31K |
| Common Stock Direct | 9/11/2019 | S · Sale | −4.21K | $2.92 | $12.29K | 9.1% | 46.31K | 42.10K |
| Total | +5.79K | -$12.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
200K shares
Shares
+200K
Strike price
1.43
Held after
200K
Exercisable
—
9/10/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock200K shares | 9/10/2019 | A · Award | +200K | 1.43 | — | 200K |